Literature DB >> 6491643

Immune response of adults to sequential influenza vaccination.

R D Powers, F G Hayden, J Samuelson, J M Gwaltney.   

Abstract

Annual immunization against influenza is recommended for numerous individuals, but the antibody response to sequential vaccination has not been well characterized. Levels of hemagglutination-inhibition antibody were measured in adults given either two or three doses of trivalent influenza vaccine at six-month intervals. A significant rise in the number of individuals with antibody titers of greater than or equal to 40 was seen for all three antigens only after initial vaccination. Repeated vaccination was necessary to maintain adequate antibody levels only to the A/Brazil (H1N1) antigen; it did not significantly affect the proportions of individuals with protective levels of antibody to either the A/Bangkok (H3N2) or the B/Singapore 222/79 antigens. These findings do not support the current recommendation for annual immunization when the vaccine formulation has not changed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491643     DOI: 10.1002/jmv.1890140211

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Variable efficacy of repeated annual influenza vaccination.

Authors:  D J Smith; S Forrest; D H Ackley; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Efficacy of the influenza vaccine in patients with malignant lymphoma.

Authors:  Joseph J Mazza; Steven H Yale; Jodi R Arrowood; Cory E Reynolds; Ingrid Glurich; Po-Huang Chyou; James G Linneman; Kurt D Reed
Journal:  Clin Med Res       Date:  2005-11

3.  The immune response to influenza vaccination in diabetic patients.

Authors:  P Pozzilli; E A Gale; N Visalli; M Baroni; P Crovari; V Frighi; M G Cavallo; D Andreani
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

4.  Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.

Authors:  G J Gorse; R B Belshe; N J Munn
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

5.  Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine.

Authors:  Manjusha Gaglani; Sarah Spencer; Sarah Ball; Juhee Song; Allison Naleway; Emily Henkle; Sam Bozeman; Sue Reynolds; Wendy Sessions; Kathy Hancock; Mark Thompson
Journal:  J Infect Dis       Date:  2013-12-19       Impact factor: 5.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.